Not using Bio­strength for BE [Regulatives / Guidelines]

posted by jag009  – NJ, 2018-07-17 06:32 (1228 d 20:01 ago) – Posting: # 19073
Views: 1,978

Hi,

» Our firm is developing a multi-strength product which is a high potency, NTI oral dosage...

1) Is 0.15mg your only strength?
2) Why you want to dose 0.15x4 and not just 0.15mg?
3) Better to file a control correspondence

J

Complete thread:

Activity
 Admin contact
21,778 posts in 4,555 threads, 1,547 registered users;
online 4 (0 registered, 4 guests [including 4 identified bots]).
Forum time: Saturday 01:33 CET (Europe/Vienna)

Every new technology to me is like a newborn baby –
and you think that it’s become president
or it’s cure cancer or win a nobel prize.
But in the end, you’re perfectly happy
when it just stays out of jail […].    Eric Betzig

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5